Milica Moskovljevic

Milica Moskovljevic

Auto-generated profile, based on publicly available information

Milica Moskovljevic

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2021 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
NBNathan L. Board
Nathan L. Board
MMMilica Moskovljevic
Milica Moskovljevic
FWFengting Wu
Fengting Wu
RSRobert F. Siliciano
Robert F. Siliciano
JSJanet D. Siliciano
Janet D. Siliciano

26 January 2024 in Nature Immunology
Verified
Journal Article
Open access
PDF file
NBNathan L. Board
Nathan L. Board
ZYZhe Yuan
Zhe Yuan
FWFengting Wu
Fengting Wu
MMMilica Moskovljevic
Milica Moskovljevic
MRMeghana Ravi
Meghana Ravi
RSRobert F. Siliciano
Robert F. Siliciano
The persistence of CD4+ T cells carrying latent human immunodeficiency virus-1 (HIV-1) proviruses is the main barrier to a cure. New therapeutics to enhance HIV-1-specific immune responses and clear infected cells will probably be necessary to achieve reduction of the latent reservoir. In the present study, we report two single-chain diabodies (scDbs) that target the HIV-1 envelope protein (Env) and the human type III Fcγ receptor (CD16). We show that the scDbs promoted robust and HIV-1-specific natural killer (NK) cell activation and NK cell-mediated lysis of infected cells. Cocultures of CD4+ T cells from people with HIV-1 on antiretroviral therapy (ART) with autologous NK cells and the scDbs resulted in marked elimination of reservoir cells that was dependent on latency reversal. Treatment of human interleukin-15 transgenic NSG mice with one of the scDbs after ART initiation enhanced NK cell activity and reduced reservoir size. Thus, HIV-1-specific scDbs merit further evaluation as potential therapeutics for clearance of the latent reservoir.

3 October 2025 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
VHVivek Hariharan
Vivek Hariharan
JWJennifer A. White
Jennifer A. White
FDFilippo Dragoni
Filippo Dragoni
EFEmily J. Fray
Emily J. Fray
NPNicholas Pathoulas
Nicholas Pathoulas
RSRobert F. Siliciano
Robert F. Siliciano
During replication of some RNA viruses, defective particles can spontaneously arise and interfere with wild-type (WT) virus replication. However, these defective interfering particles (DIPs) have not been reported in people with HIV-1 (PWH). Here we find DIPs in PWH who have a rare, polyclonal form of non-suppressible viraemia (NSV). We characterized the source of NSV in two PWH who never reached undetectable viral load despite adherence to antiretroviral therapy (ART). Remarkably, in each participant, we found a diverse set of defective viral genomes sharing the same fatal deletions. This paradoxical accumulation of mutations by viruses with fatal defects was driven by superinfection with intact viruses, resulting in mobilization of defective genomes and accumulation of additional mutations during untreated infection. These defective proviruses interfere with WT virus replication, conditionally replicate and, in one case, have an R 0 > 1, enabling in vivo spread. Despite this, clinical outcomes showed no beneficial effect of these DIPs. These findings demonstrate that fatally defective proviruses, traditionally considered evolutionary dead ends, can replicate and diversify upon superinfection without preventing disease progression.

13 August 2025 in Science Translational Medicine
Verified
Journal Article
Closed access
FWFengting Wu
Fengting Wu
MMMilica Moskovljevic
Milica Moskovljevic
FDFilippo Dragoni
Filippo Dragoni
SJSahana Jayaraman
Sahana Jayaraman
NBNathan L. Board
Nathan L. Board
FSFrancesco R. Simonetti
Francesco R. Simonetti
Antiretroviral therapy (ART) halts human immunodeficiency virus–1 (HIV-1) replication, reducing plasma virus concentrations to below the limit of detection, but it is not curative because of a reservoir of latently infected CD4 + T cells. In some people living with HIV-1 (PLWH), plasma HIV-1 RNA becomes persistently detectable despite optimal ART. This nonsuppressible viremia (NSV) is characterized by identical, nonevolving HIV-1 RNA variants expressed from infected CD4 + T cell clones. The mechanisms driving persistent virus production from a specific population of infected cells are poorly understood. We hypothesized that proviruses in cells responding to chronic immunologic stimuli, including self-associated antigens, may drive viral gene expression and NSV. Here, we demonstrate that stimulation of CD4 + T cells with autologous cell lysates induced virus production in a major histocompatibility complex class II–dependent manner. In seven of eight participants with NSV, we recovered viral RNA released ex vivo in response to autologous cell lysates that matched plasma virus. This process involved both defective and replication-competent proviruses residing in conventional CD4 + T cells and was also observed in PLWH with undetectable viremia. These findings suggest that recognition of self-associated antigens is a potentially important cause of HIV-1 reservoir expression, which can contribute to persistent systemic inflammation and rebound upon ART interruption.

1 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MMMilica Moskovljevic
Milica Moskovljevic
FDFilippo Dragoni
Filippo Dragoni
NBNathan L. Board
Nathan L. Board
FWFengting Wu
Fengting Wu
JLJun Lai
Jun Lai
RSRobert F. Siliciano
Robert F. Siliciano
Summary: Despite antiretroviral therapy (ART), HIV-1 persists in latently-infected CD4 + T cells, preventing cure. Antigens drive the proliferation of infected cells, precluding latent reservoir decay. However, the relationship between antigen recognition and HIV-1 gene expression is poorly understood since most studies of latency reversal use agents that induce non-specific global T cell activation. Here, we isolated rare CD4 + T cells responding to cytomegalovirus (CMV) or HIV-1 Gag antigens from participants on long-term ART and assessed T cell activation and HIV-1 RNA expression upon co-culture with autologous dendritic cells (DCs) presenting cognate antigens. Physiological presentation of cognate antigens induced broad T cell activation (median 42-fold increase in CD154 + CD69 + cells) and significantly increased HIV-1 transcription (median 4-fold), mostly through the induction of rare cells with higher viral expression. Thus, despite low proviral inducibility, physiologic antigen recognition can promote HIV-1 expression, potentially contributing to spontaneous reservoir activity on ART and viral rebound upon ART interruption.

5 December 2025 in Journal of Experimental Medicine
Verified
Journal Article
Open access
KRKyle Rhodehouse
Kyle Rhodehouse
CZCarolin Zitzmann
Carolin Zitzmann
MRMeghana Ravi
Meghana Ravi
CACiara Armstrong
Ciara Armstrong
MMMilica Moskovljevic
Milica Moskovljevic
RSRobert F. Siliciano
Robert F. Siliciano
Insights into HIV-1 pathogenesis have come from studies of viral dynamics. However, there is little information on viral dynamics in lentiviral infections in which viral replication is naturally controlled in a subset of infected individuals. We evaluated the decay of simian immunodeficiency virus (SIV) RNA and cell-associated SIV genomes in a nonhuman primate (NHP) model in which replication of an engineered SIV variant is naturally controlled by cellular immune responses in most infected animals. This variant lacks a trafficking motif in the gp41 cytoplasmic tail. A trajectory of control was evident by 21 days after infection. In animals with natural control, we observed similar biphasic decay of intact proviruses in blood and lymph nodes, at rates close to those in animals that failed to control the virus and were put on antiretroviral therapy (ART). Both natural control and ART effectively blocked viral evolution, but not persistence. Thus, in this NHP model, natural control can be nearly as effective as ART in controlling viral replication.